Positive surgical margins and durable disease control: A case of adenoid cystic carcinoma of the parotid gland treated with adjuvant radiotherapy

Read full text Summarise with VIRAT
Authors: Nouhaila Kanouni, Sofia RESMOUKI, Samia Khalfi, Kaoutar Soussy, Wissal Hassani, Fatima Zahra Farhane, Zineb Alami, Touria BOUHAF
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The parotid gland, the main site of adenoid cystic carcinoma (ACC) among the major salivary glands, represents a clinically significant location, particularly when the deep lobe is involved. This case illustrates the clinical and evolutionary heterogeneity of parotid adenoid cystic carcinoma. Despite the presence of positive surgical margins, adjuvant radiotherapy achieved durable locoregional control. We report the case of a 45-year-old woman who presented with left-sided otalgia and headaches evolving over a two-year period. Magnetic Resonance Imaging (MRI) revealed a mass arising from the deep lobe of the left parotid gland. Total parotidectomy demonstrated adenoid cystic carcinoma with positive margins but without perineural invasion. Exclusive adjuvant radiotherapy was administered. After three years of clinical and radiological follow-up, the outcome remains favorable, with no evidence of local recurrence or distant metastasis. We present the clinical, radiological, and therapeutic challenges raised by this adenoid cystic carcinoma of the deep lobe of the parotid gland, then analyze its underlying mechanisms and compare our observation with data from the literature.

Fields of Study & Subjects

Salivary Gland Tumors Diagnosis and Treatment Salivary Gland Disorders and Functions Adrenal and Paraganglionic Tumors

Publication details

Journal / source
World Journal of Advanced Research and Reviews
Volume
29
Issue
3
Pages
1295–1301
Publication date
21 March 2026
Language
EN